Hudson Bay Capital Management
AGN

Hudson Bay Capital Management’s Allergan plc AGN Stock Holding History

Hudson Bay Capital Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-464,800
Closed -$82.3M – 672
2020
Q1 		$82.3M Buy
+464,800
New +$87.5M 2.06% 10
2014
Q4 		– Sell
-150,000
Closed -$36.2M – 245
2014
Q3 		$36.2M Buy
+150,000
New +$33.6M 1.02% 24
2013
Q3 		– Sell
-50,000
Closed -$6.31M – 200
2013
Q2 		$6.31M Buy
+50,000
New +$5.66M 0.34% 64

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $5.64B AUM 18.33% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Hudson Bay Capital Management's AGN Position: Q2 2020 in Review

Hudson Bay Capital Management sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 1,053,589 shares — an estimated $187M sold.

Hudson Bay Capital Management first reported a position in AGN in Q2 2013 and held it in 14 quarters. The position peaked at $187M in Q1 2020. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Hudson Bay Capital Management reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Hudson Bay Capital Management sold 1,053,589 Allergan plc shares in Q2 2020, an estimated $187M.
  • Hudson Bay Capital Management first reported a position in Allergan plc in Q2 2013 and held it in 14 quarters.
  • Hudson Bay Capital Management's Allergan plc position peaked at $187M in Q1 2020.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Hudson Bay Capital Management's 13F filing for Q2 2020, filed 12 Aug 2020.